Pulmonx Corporation
LUNG
$1.62
-$0.01-0.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 91.66M | 90.55M | 87.47M | 83.79M | 79.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 91.66M | 90.55M | 87.47M | 83.79M | 79.30M |
| Cost of Revenue | 24.48M | 24.39M | 23.21M | 21.79M | 20.49M |
| Gross Profit | 67.19M | 66.16M | 64.27M | 62.00M | 58.81M |
| SG&A Expenses | 105.46M | 105.27M | 103.88M | 102.14M | 99.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 148.84M | 147.46M | 145.20M | 141.49M | 137.51M |
| Operating Income | -57.18M | -56.91M | -57.73M | -57.70M | -58.21M |
| Income Before Tax | -56.28M | -56.40M | -56.64M | -55.89M | -56.40M |
| Income Tax Expenses | 478.00K | 542.00K | 449.00K | 500.00K | 710.00K |
| Earnings from Continuing Operations | -56.75 | -56.94 | -57.09 | -56.39 | -57.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.75M | -56.94M | -57.09M | -56.39M | -57.11M |
| EBIT | -57.18M | -56.91M | -57.73M | -57.70M | -58.21M |
| EBITDA | -56.06M | -55.67M | -56.38M | -56.21M | -56.72M |
| EPS Basic | -1.41 | -1.43 | -1.45 | -1.44 | -1.47 |
| Normalized Basic EPS | -0.87 | -0.89 | -0.90 | -0.89 | -0.91 |
| EPS Diluted | -1.41 | -1.43 | -1.45 | -1.44 | -1.47 |
| Normalized Diluted EPS | -0.87 | -0.89 | -0.90 | -0.89 | -0.91 |
| Average Basic Shares Outstanding | 160.90M | 159.24M | 157.76M | 156.44M | 155.23M |
| Average Diluted Shares Outstanding | 160.90M | 159.24M | 157.76M | 156.44M | 155.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |